$0.258000
-0.05-15.27%
At Close: -
$0.277400
0.027.52%
After Hours: 5:37 PM EDT
15 minutes delayed
Cara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cara Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CARA | Cara Therapeutics | -$0.58 | — | — | — | $6.93M | — | — | — | 08/05/2024 | Get Alert |
CARA | Cara Therapeutics | -$0.49 | -$0.40 | -$0.56 | -40.00% | $6.17M | $1.69M | $2.13M | 26.33% | 05/13/2024 | Get Alert |
CARA | Cara Therapeutics | -$0.56 | -$0.41 | -$0.59 | -43.90% | $3.26M | $9.42M | $3.00M | -68.11% | 03/04/2024 | Get Alert |
CARA | Cara Therapeutics | -$0.43 | -$0.52 | -$0.52 | 0.00% | $10.81M | $9.95M | $4.87M | -51.10% | 11/13/2023 | Get Alert |
CARA | Cara Therapeutics | -$0.08 | -$0.56 | -$0.58 | -3.57% | $23.00M | $6.49M | $6.93M | 6.83% | 08/07/2023 | Get Alert |
CARA | Cara Therapeutics | -$0.52 | -$0.52 | -$0.49 | 5.77% | $4.79M | $4.98M | $6.17M | 23.80% | 05/15/2023 | Get Alert |
CARA | Cara Therapeutics | -$0.63 | -$0.32 | -$0.56 | -75.00% | $821.00K | $16.25M | $3.26M | -79.93% | 03/06/2023 | Get Alert |
CARA | Cara Therapeutics | -$0.02 | -$0.42 | -$0.43 | -2.38% | $20.27M | $9.83M | $10.81M | 10.00% | 11/07/2022 | Get Alert |
CARA | Cara Therapeutics | -$0.61 | -$0.25 | -$0.08 | 68.00% | $0.00 | $20.71M | $23.00M | 11.07% | 08/08/2022 | Get Alert |
CARA | Cara Therapeutics | -$0.47 | -$0.54 | -$0.52 | 3.70% | $1.94M | $3.16M | $4.79M | 51.58% | 05/09/2022 | Get Alert |
CARA | Cara Therapeutics | $1.59 | -$0.52 | -$0.63 | -21.15% | $112.09M | $1.46M | $821.00K | -43.77% | 03/01/2022 | Get Alert |
CARA | Cara Therapeutics | -$0.35 | -$0.40 | -$0.02 | 95.00% | $9.27M | $11.21M | $20.27M | 80.84% | 11/08/2021 | Get Alert |
CARA | Cara Therapeutics | -$0.54 | -$0.53 | -$0.61 | -15.09% | $5.63M | $2.36M | $0.00 | -100.00% | 08/09/2021 | Get Alert |
CARA | Cara Therapeutics | -$0.62 | -$0.59 | -$0.47 | 20.34% | $8.09M | $2.36M | $1.94M | -18.01% | 05/10/2021 | Get Alert |
CARA | Cara Therapeutics | -$0.61 | $0.36 | $1.59 | 341.67% | $4.51M | $48.63M | $112.09M | 130.49% | 02/25/2021 | Get Alert |
CARA | Cara Therapeutics | -$0.74 | -$0.60 | -$0.35 | 41.67% | $5.79M | $4.77M | $9.27M | 94.26% | 11/09/2020 | Get Alert |
CARA | Cara Therapeutics | -$0.58 | -$0.67 | -$0.54 | 19.40% | $5.21M | $5.06M | $5.63M | 11.34% | 08/10/2020 | Get Alert |
CARA | Cara Therapeutics | -$0.56 | -$0.62 | -$0.62 | 0.00% | $4.38M | $4.76M | $8.09M | 70.02% | 05/11/2020 | Get Alert |
CARA | Cara Therapeutics | -$0.52 | -$0.66 | -$0.61 | 7.58% | $5.53M | $4.79M | $4.51M | -5.82% | 02/27/2020 | Get Alert |
CARA | Cara Therapeutics | -$0.51 | -$0.58 | -$0.74 | -27.59% | $5.06M | $4.34M | $5.79M | 33.29% | 11/05/2019 | Get Alert |
CARA | Cara Therapeutics | -$0.52 | -$0.61 | -$0.58 | 4.92% | $2.87M | $3.05M | $5.21M | 70.75% | 08/07/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-13 | $-0.56 | $-0.40 | -40.0 % |
Dec 2023 | 2024-03-04 | $-0.59 | $-0.41 | -43.9 % |
Sep 2023 | 2023-11-13 | $-0.52 | $-0.52 | 0.00 % |
Jun 2023 | 2023-08-07 | $-0.58 | $-0.56 | -3.57 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-13 | $2.13M | $1.69M | 26.3 % |
Dec 2023 | 2024-03-04 | $3.00M | $9.42M | -68.1 % |
Sep 2023 | 2023-11-13 | $4.87M | $9.95M | -51.1 % |
Jun 2023 | 2023-08-07 | $6.93M | $6.49M | 6.83 % |
Cara Therapeutics (CARA) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
The Actual EPS was $-0.56, which missed the estimate of $-0.40.
The Actual Revenue was $2.1M, which beat the estimate of $1.7M.
Browse earnings estimates, EPS, and revenue on all stocks.